Allianz’s Bristol-Myers Squibb BMY Stock Holding History

Allianz’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.7M	Sell	94,033 -9,817	-9%	-$572K	0.06%	164
2025 Q4	$5.6M	Buy	103,850 +9,817	+10%	+$472K	0.07%	150
2025 Q3	$4.24M	Sell	94,033 -590	-0.6%	-$27.6K	0.09%	147
2025 Q2	$4.38M	Sell	94,623 -5,501	-5%	-$270K	0.1%	144
2025 Q1	$6.11M	Sell	100,124 -1,163	-1%	-$67.8K	0.16%	122
2024 Q4	$5.68M	Sell	101,287 -25,031	-20%	-$1.4M	0.15%	121
2024 Q3	$6.54M	Buy	126,318 +24,623	+24%	+$1.16M	0.18%	115
2024 Q2	$4.22M	Sell	101,695 -14,888	-13%	-$666K	0.12%	127
2024 Q1	$6.32M	Buy	+116,583	New	+$5.94M	0.2%	115

Other funds holding BMY

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return